Neurally Adjusted Ventilatory Assist
Neurally Adjusted Ventilatory Assist is a medical device with 12 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study
Neurally Adjusted Ventilatory Assist for Neonates With Congenital Diaphragmatic Hernias
Lung Protection in ARDS Using Neurally Adjusted Ventilatory Assist
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants
Clinical Trials (12)
NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study
Neurally Adjusted Ventilatory Assist for Neonates With Congenital Diaphragmatic Hernias
Lung Protection in ARDS Using Neurally Adjusted Ventilatory Assist
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants
Conventional vs Neurally Adjusted Ventilatory Assist in Difficult Weaning From Mechanical Ventilation
NAVA Unloading - Effects on Distribution of Ventilation
Impact of the Assisted Ventilation Mode on Diaphragm Efficiency in Critically Ill Patients
NAVASET: Nava Level Titration Using Comfort Scales
NAVA Helmet in Pediatric Respiratory Failure
Neurally Adjusted Ventilatory Assist for Non Invasive Ventilation and Patient-ventilator Interaction
Non-invasive Neurally Adjusted Ventilatory Assist in Healthy Volunteers
All 12 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 12